Liver Transplant Outcomes in Patients with Atrial Fibrillation.

被引：0
|
作者：
Devuni, D. [1 ]
Mahboub, P. [2 ]
Martins, P. [2 ]
Barry, C. [1 ]
Zacharias, I. [1 ]
Movahedi, B. [2 ]
Barnard, G. [1 ]
Bozorgzadeh, A. [2 ]
机构：
[1] Univ Massachusetts, Sch Med, Div Gastroenterol, Worcester, MA USA
[2] Univ Massachusetts, Sch Med, Div Transplantat, Surg, Worcester, MA USA
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2019年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
A320
引用
收藏
页码：719 / 720
页数：2
相关论文
共 50 条
  • [1] Outcomes of patients with a myeloproliferative neoplasm and atrial fibrillation.
    Leiva, Orly
    How, Chi-Joan
    Brunner, Andrew
    Grevet, Jeremy
    Hobbs, Gabriela
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [2] Atrial fibrillation inducibility in patients with no prior atrial fibrillation.
    Boonyapisit, Warangkna
    Mukerji, Siddharth
    Chen-Scarabelli, Carol
    McLemore, Rita
    Pelosi, Frank
    Oral, Hakan
    Bogun, Frank
    Chugh, Aman
    Good, Eric
    Thakur, Ranjan
    Morady, Fred
    Jongnarangsin, Krit
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2007, 49 (09) : 14A - 14A
  • [3] Obesity Severity and Clinical Outcomes in Atrial Fibrillation.
    Qin, Dingxin
    Sharbaugh, Michael
    Thoma, Floyd
    Althouse, Andrew D.
    Koscumb, Stephen
    Malecky, Amanda
    Marroquin, Oscar
    Saba, Samir
    Kershaw, Erin E.
    Mulukutla, Suresh
    Cavalcante, Joao
    CIRCULATION, 2018, 138
  • [4] The real world management and outcomes of atrial fibrillation.
    Nemerovski, Carrie W.
    Chopra, Anuvrat
    Jacob, Minu
    Hassan, Sonia
    Kalus, James S.
    PHARMACOTHERAPY, 2013, 33 (05): : E64 - E64
  • [5] Dabigatran versus Warfarin in Patients with Atrial Fibrillation.
    Connolly, Stuart J.
    Ezekowitz, Michael D.
    Yusuf, Salim
    Eikelboom, John
    Oldgren, Jonas
    Parekh, Amit
    Pogue, Janice
    Reilly, Paul A.
    Themeles, Ellison
    Varrone, Jeanne
    Wang, Susan
    Alings, Marco
    Xavier, Denis
    Zhu, Jun
    Diaz, Rafael
    Lewis, Basil S.
    Darius, Harald
    Diener, Hans-Christoph
    Joyner, Campbell D.
    Wallentin, Lars
    NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (12): : 1139 - 1151
  • [6] Pharmacogenomics of atrial fibrillation.
    Donahue, BS
    Darbar, D
    George, AL
    Li, C
    Brown, NJ
    Ritchie, M
    Roden, DM
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2005, 77 (02) : P7 - P7
  • [7] Outcomes of antiarrhythmic drug therapy in patients with systolic heart failure and atrial fibrillation.
    Stiegler, KA
    Franks, AM
    Granberry, MC
    Hawkins, JB
    Smith, ES
    PHARMACOTHERAPY, 2003, 23 (03): : 391 - 391
  • [8] Dabigatran versus warfarin in patients with atrial fibrillation.
    Lundelin, K.
    REVISTA CLINICA ESPANOLA, 2010, 210 (03): : 139 - 140
  • [9] Non-Alcoholic Fatty Liver Disease and Atrial Fibrillation. Prevalence and Impact on Clinical Outcomes
    Pastori, Daniele
    Sciacqua, Angela
    Marcucci, Rossella
    Farcomeni, Alessio
    Perticone, Francesco
    Del Ben, Maria
    Angelico, Francesco
    Pignatelli, Pasquale
    Violi, Francesco
    CIRCULATION, 2019, 140
  • [10] Prevalence, Predictors, and Outcomes of Patients With Tachycardia-Related Cardiomyopathy Due to Atrial Fibrillation.
    Techawantochandej, Athittaya
    Lee, Hon-Chi
    Gersh, Bernard J.
    Wysokinski, Waldemar E.
    Patlolla, Sri Harsha
    Greene, Eddie L.
    Oh, Jae K.
    Melduni, Rowlens M.
    CIRCULATION, 2018, 138
12345